RetroSense

RetroSense

RetroSense

Dedicated to vision restoration in retinal degenerative conditions like retinitis pigmentosa and dry AMD.
Founded
2009
Raised
$6.1M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$75,000
Seed fund - 2011
Team Size
1–10
Employees
$60,000,000
Xconomy

Allergan Dips Toes into Gene Therapy With $60M Retrosense Buy

Health Science
Xconomy

Roundup: RetroSense, America's Greatest Makers, Naturalicious & More

Education
$6,000,000 Venture capital (Series A)
PE Hub

Biotech firm RetroSense Therapeutics picks up $6 mln